The use of oral contraceptives is a well-established acquired risk factor for venous
thrombosis. In 1995, a number of epidemiological studies were published which suggested …

In the transient period that we are waiting for the füll report of the independent Scientific
Group Meeting on Cardiovascular Disease and Steroid Hormone Contraceptives [World …

To assess the risk of thromboembolism in women using oral contraceptives (OCs), we
identified through computer search in the hospitals of the province of Parma, Italy, all women …

There are indications in the literature that asymptomatic women with an inherited
thrombophilic defect who use oral contraceptive have an increased risk of venous …

Background The risk of venous thromboembolism (VTE) in women taking combined oral
contraceptives (COCs) is attributed to changes in coagulation and fibrinolysis. Their impact …

The use of oral contraceptives (OC) is a well established risk factor for venous thrombosis. It
has been known for many years that almost all haemostatic parameters ie plasma levels of …

Objectives To investigate the factors associated with idiopathic venous thromboembolism in
combined oral contraceptive users and to estimate the crude and age-specific incidence …

Background The aim was to assess the risk of venous thromboembolism (VTE) associated
with use of combined oral contraceptives (COCs) in women with a family history of VTE …

Objective This article estimates the interaction between types of combined hormonal
contraception (CHC) and factor V Leiden (FVL) mutation on the risk of venous thrombosis …

Hemostasis in women is influenced by physiological changes in hormone status associated
with the menstrual cycle, pregnancy and hormone-based contraceptives, and hormone …